Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000041207
JPRN-UMIN000041207
Completed
未知

Evaluation of the accuracy of prostate cancer diagnosis with carbohydrate biomarker test - Evaluation of the accuracy of prostate cancer diagnosis with carbohydrate biomarker test

Tokai University0 sites204 target enrollmentJuly 25, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSuspected prostate cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Suspected prostate cancer
Sponsor
Tokai University
Enrollment
204
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 25, 2020
End Date
March 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\. Person who are considered as worsen their health condition due to blood test. 2\. Person who are regarded as inappropriate for the study by the researcher.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Detection of clinically significant prostate cancer with MRI-TRUS fusion image-guided biopsy: comparison of the evaluation system (PI-RADS category vs. PI-RADS + US evalutaion)Suspected prostate cancer
JPRN-UMIN000050631Tokai University80
Recruiting
Not Applicable
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancer
JPRN-UMIN000019278Kyoto University2,000
Completed
Phase 3
Accuracy of lymph node imaging in prostate cancer: A prospective cohort study to determine the concordance between two imaging modalities, *Combidex* magnetic resonance imaging (Nano MRI) and 68Ga-PSMA positron emission tomography (PET).Prostate cancerLymph node metastasis10027476
NL-OMON45969Radboud Universitair Medisch Centrum80
Active, not recruiting
Phase 1
Metastasis assessment with Gallium-68 PSMA and Nanoparticle Imaging.Detection of lymph node metastasis in prostate cancer.Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2015-005016-15-NLRadboudumc80
Recruiting
Not Applicable
Diagnostic performance of Prostate HistoScanningTM (PHS) in men at risk of prostate cancer scheduled for an initial prostate biopsy.Subjects suspected to have PCa who are schedules for a first prostate biopsy.C61Malignant neoplasm of prostate
DRKS00005263Advanced Medical Diagnostics SAWaterloo Office Park Bât i bte 3391